N-LIFT
Live / Registered — Registered (as of 19 Nov 2024)
What this means for you
Registered since 19 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98095914
- Registration number
- 7568537
- Mark type
- Stylized text
- Filed
- 21 Jul 2023
- Published for opposition
- 03 Sept 2024
- Registered
- 19 Nov 2024
- Attorney of record
- Steven E. Lauridsen
Goods and services
- Class 001 — Chemicals: Media for cell culture for research use in the biotechnological industry, all of the aforesaid being for use in cell therapy, living cell therapy and the treatment of cancer
- Class 005 — Pharmaceuticals: Biotechnological immune cell preparations for medical use, all of the aforesaid being for use in cell therapy, living cell therapy and the treatment of cancer; media for cell culture for medical use in the biotechnological industry, all of the aforesaid being for use in cell therapy, living cell therapy and the treatment of cancer
- Class 042 — Scientific and technological services: Biotechnological research; Research relating to biotechnology; Research and development in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; all of the aforesaid relating to cell therapy, living cell therapy and the treatment of cancer
Owner
- LIfT BioSciences Limited, London, GB
- LIfT BioSciences Limited, London, GB
- LIfT BioSciences Limited, London, GB
Prosecution history
- 19 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 03 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Sept 2024 — PUBLISHED FOR OPPOSITION
- 14 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Mar 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Mar 2024 — NON-FINAL ACTION E-MAILED
- 27 Mar 2024 — NON-FINAL ACTION WRITTEN
- 26 Mar 2024 — ASSIGNED TO EXAMINER
- 28 Jan 2024 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 25 Jan 2024 — ASSIGNED TO LIE